Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Naltrexone plus aripiprazole for alcohol dependence
NCT00667875Phase 2Completed
- Sponsor
- Medical University of South Carolina
- Start
- Apr 2008
- Primary completion
- May 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of aripiprazole in alcohol dependence (3 arms), sponsored by Medical University of South Carolina. Primary endpoints: Drinks Per Drinking Day at 16 weeks and Percent Heavy Drinking Days at 16 weeks. Started Apr 2008; status: completed.
02
Drugs
aripiprazole
03
Conditions
alcohol dependence
Beyond the preview
Go deeper on NCT00667875.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00667875.